CD79A and psychotic disorder: The type of neural autoantibody, such as NMDAR IgG compared to NMDAR IgA, or IgM in relation to the patient’s clinical presentation (such as amnestic syndrome and psychosis) might be key to the pathogenicity of neural autoantibodies, and a factor that should be always kept in mind.